UPLOAD Filing
PharmaCyte Biotech, Inc.
Date: Sept. 23, 2025 · CIK: 0001157075 · Accession: 0000000000-25-010346
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290311
Letter
Re: PharmaCyte Biotech, Inc. Registration Statement on Form S-3 Filed September 17, 2025 File No. 333-290311 Dear Carlos Trujillo:
September 23, 2025
Carlos Trujillo Chief Financial Officer PharmaCyte Biotech, Inc. 3960 Howard Hughes Parkway, Suite 500 Las Vegas, NV 89169
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Kenneth Koch
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> September 23, 2025 Carlos Trujillo Chief Financial Officer PharmaCyte Biotech, Inc. 3960 Howard Hughes Parkway, Suite 500 Las Vegas, NV 89169 Re: PharmaCyte Biotech, Inc. Registration Statement on Form S-3 Filed September 17, 2025 File No. 333-290311 Dear Carlos Trujillo: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Kenneth Koch </TEXT> </DOCUMENT>